Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 4/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20524233 | 1.00 | BLM (0.38) | BLMPMP22HSD17B10MEN1KMT2A | |
| SCHEMBL19865167 | 1.00 | BLM (0.38) | BLMPMP22HSD17B10MEN1KMT2A | |
| SCHEMBL25688557 | 0.88 | MEN1 (0.42) | BLMPMP22HSD17B10MEN1KMT2A | |
| SCHEMBL10963298 | 0.87 | MEN1 (0.50) | BLMPMP22HSD17B10MEN1KMT2A | |
| SCHEMBL11057871 | 0.87 | BLM (0.40) | BLMPMP22HSD17B10MEN1KMT2A | |
| SCHEMBL10960898 | 0.87 | MEN1 (0.50) | BLMPMP22HSD17B10MEN1KMT2A | |
| SCHEMBL10957938 | 0.87 | MEN1 (0.50) | BLMPMP22HSD17B10MEN1KMT2A | |
| SCHEMBL10961389 | 0.87 | MEN1 (0.50) | BLMPMP22HSD17B10MEN1KMT2A | |
| SCHEMBL10962338 | 0.87 | MEN1 (0.50) | BLMPMP22HSD17B10MEN1KMT2A | |
| SCHEMBL19344639 | 0.87 | BLM (0.40) | BLMPMP22HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115942958-A | Phthalocyanine dye compounds, conjugates and methods of use thereof | 乐天医药生技股份有限公司 | 2023-04-07 | — | — | CN | disclosed |
| US-20180044280-A1 | Y-TYPE DISCRETE POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREOF | JENKEM TECHNOLOGY CO., LTD. (BEIJING) (CN) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180044280-A1 | Y-TYPE DISCRETE POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREOF | IDUA, YWHAZ, DDOST | BLM 810/4885PMP22 336/4885HSD17B10 2701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.